View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Vasculitis and Giant Cell Arteritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 21, 2020
3 min read
Save

Rituximab successfully re-induces remission after ANCA-associated vasculitis relapse

Rituximab successfully re-induces remission after ANCA-associated vasculitis relapse

Rituximab, used alongside glucocorticoids, is highly efficacious in re-inducing remission among relapsed patients with ANCA-associated vasculitis, according data published in Annals of the Rheumatic Diseases.

SPONSORED CONTENT
July 17, 2020
1 min read
Save

Establishing EGPA Diagnosis and Prognosis

Learning Objectives:

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
July 13, 2020
3 min read
Save

Behcet's disease remains largely unknown among physicians

Behcet's disease remains largely unknown among physicians

The rare and complex Behcet’s disease is often misdiagnosed or undiagnosed, leading to significant, but unnecessary, morbidity, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

SPONSORED CONTENT
July 10, 2020
2 min read
Save

COVID-19 infection rate in patients treated with DMARDs consistent with general population

COVID-19 infection rate in patients treated with DMARDs consistent with general population

The incidence and severity of COVID-19 among patients with rheumatic disease treated with targeted synthetic or biological DMARDs is consistent with those in the general population, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
July 08, 2020
2 min read
Save

Serious infection-related hospitalization rates nearly doubled in vasculitis

Serious infection-related hospitalization rates nearly doubled in vasculitis

The rate of hospitalizations due to serious infection in patients with vasculitis nearly doubled over a 19-year period, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
July 02, 2020
2 min read
Save

Rituximab safe for long-term use in granulomatosis with polyangiitis, microscopic polyangiitis

Rituximab safe for long-term use in granulomatosis with polyangiitis, microscopic polyangiitis

The long-term safety of rituximab was consistent with a shorter duration of treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
June 24, 2020
2 min read
Save

Secukinumab safe, effective for Behçet's phenotype resistant to conventional treatment

Secukinumab safe, effective for Behçet's phenotype resistant to conventional treatment

Secukinumab was safe and effective for Behçet’s syndrome among patients with a mucosal and articular phenotype refractory to previous conventional and biologic treatments, according to data published in the Annals of the Rheumatic Diseases.

SPONSORED CONTENT
June 23, 2020
3 min read
Save

ACR unveils guidance for multisystem inflammatory syndrome in children with COVID-19

ACR unveils guidance for multisystem inflammatory syndrome in children with COVID-19

Multisystem inflammatory syndrome in children associated with COVID-19 may share overlapping clinical features with Kawasaki Disease unrelated to the pandemic, according to guidelines released by the American College of Rheumatology.

SPONSORED CONTENT
June 18, 2020
4 min read
Save

Patients with rheumatic disease, COVID-19 more likely to require ventilation

Patients with rheumatic disease, COVID-19 more likely to require ventilation

Patients with rheumatic diseases plus COVID-19 are more likely to require mechanical ventilation, but demonstrated similar clinical features and hospitalization rates as those with COVID-19 only, according to data published in the Annals of the Rheumatic Diseases.

SPONSORED CONTENT
June 12, 2020
2 min read
Save

Prolonged rituximab linked to lower ANCA-associated vasculitis relapse

Prolonged rituximab linked to lower ANCA-associated vasculitis relapse

A biannual regimen of rituximab infusions over the course of 18 months was associated with a lower incidence of relapse in ANCA-associated vasculitis, compared with standard maintenance therapy, according to data published in the Annals of Internal Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails